Larimar Therapeutics Competitor Insights

Larimar Therapeutics is a clinical-stage biotechnology company that focuses on developing treatments for complex rare diseases. Their primary focus is on Friedreich's ataxia, for which they are developing a protein replacement therapy called CTI-1601 (nomlabofusp). They aim to deliver missing proteins directly into cells to address these underserved medical needs.